NCT07057596
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07057596
Title Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma (NEO-TB)
Acronym NEO-TB
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Grupo Espanol Multidisciplinar de Melanoma
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP | DEU


No variant requirements are available.